Brief: Epigenomics Sees 2020 Revenues Within Range Of EUR 1.0-2.0 Mln

Epigenomics AG

29/04/2020 07:08

April 29 (Reuters) - Epigenomics AG  ECXn.DE :
    * DGAP-NEWS: EPIGENOMICS AG REPORTS FINANCIAL RESULTS FOR FISCAL YEAR 2019 AND PRELIMINARY
UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2020
    * FY TOTAL REVENUE DECREASED TO EUR 1.1 MILLION
    * FY DECLINE IN EBITDA (BEFORE SHARE-BASED PAYMENT EXPENSES) TO EUR -13.3 MILLION
    * Q1 EBITDA (BEFORE SHARE-BASED PAYMENT EXPENSES) IMPROVED SLIGHTLY FROM EUR -3.0 MILLION
(Q1
2019) TO EUR -2.6 MILLIO
    * FY NET LOSS FOR YEAR INCREASED TO APPROXIMATELY EUR -17.0 MILLION
    * Q1 REVENUES OF EUR 0.2 MILLION IN Q1 OF 2020 (Q1 2019: EUR 0.3 MILLION)
    * OUTLOOK 2020: EXPECTS REVENUE FOR FISCAL YEAR 2020 WITHIN RANGE OF EUR 1.0 MILLION TO EUR
2.0
MILLION
    * OUTLOOK 2020: EBITDA (BEFORE SHARE-BASED PAYMENT EXPENSES) IS EXPECTED TO RANGE FROM EUR
-10.5
MILLION TO EUR -12.5 MILLION
    * Q1 NET LOSS IMPROVED SLIGHTLY FROM EUR -3.0 MILLION (Q1 2019) TO EUR -2.9 MILLION

Source text for Eikon:  ID:nEQ1pFJCBa 
Further company coverage:  ECXn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))